Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 5.42 GBX -3.21% Market Closed
Market Cap: 258.3m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Allergy Therapeutics PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allergy Therapeutics PLC
Operating Income Peer Comparison

Comparables:
GSK
AZN
VRNA
HIK
DPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Allergy Therapeutics PLC
LSE:AGY
Operating Income
-ÂŁ38.8m
CAGR 3-Years
N/A
CAGR 5-Years
-74%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Operating Income
ÂŁ7.6B
CAGR 3-Years
2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Operating Income
$10.3B
CAGR 3-Years
34%
CAGR 5-Years
19%
CAGR 10-Years
13%
Verona Pharma PLC
NASDAQ:VRNA
Operating Income
-$155.4m
CAGR 3-Years
-37%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$617m
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
3%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
ÂŁ24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%

See Also

What is Allergy Therapeutics PLC's Operating Income?
Operating Income
-38.8m GBP

Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Operating Income amounts to -38.8m GBP.

What is Allergy Therapeutics PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-74%

Over the last year, the Operating Income growth was -43%.

Back to Top